ARROWHEAD PHARMACEUTICALS, INC. financial data

Symbol
ARWR on Nasdaq
Location
Pasadena, CA
Fiscal year end
30 September
Latest financial report
10-K - Q3 2025 - 25 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 512 % -12.6%
Return On Equity -0.37 % +99.8%
Return On Assets -0.12 % +99.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 135,809,558 shares +7.7%
Common Stock, Shares, Outstanding 135,702,000 shares +9.1%
Entity Public Float 1,400,000,000 USD -53.3%
Common Stock, Value, Issued 231,000 USD +6.5%
Weighted Average Number of Shares Outstanding, Basic 133,758,000 shares +11.7%
Weighted Average Number of Shares Outstanding, Diluted 133,758,000 shares +11.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 829,448,000 USD +232.6%
General and Administrative Expense 123,943,000 USD +25.5%
Operating Income (Loss) 98,346,000 USD
Nonoperating Income (Expense) -46,813,000 USD -3.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 51,533,000 USD
Income Tax Expense (Benefit) 4,729,233 USD
Net Income (Loss) Attributable to Parent -1,631,000 USD +99.7%
Earnings Per Share, Basic 0 USD/shares +99.8%
Earnings Per Share, Diluted 0 USD/shares +99.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 69,400,000 USD -34.1%
Accounts Receivable, after Allowance for Credit Loss, Current 6,824,000 USD
Other Assets, Current 13,516,000 USD +1.7%
Assets, Current 950,639,000 USD +36.7%
Property, Plant and Equipment, Net 382,515,000 USD -0.91%
Operating Lease, Right-of-Use Asset 43,891,000 USD -3%
Other Assets, Noncurrent 1,389,000 USD -69%
Assets 1,385,295,000 USD +21.5%
Accounts Payable, Current 17,674,000 USD +55.2%
Employee-related Liabilities, Current 26,895,000 USD +22.3%
Accrued Liabilities, Current 90,419,000 USD +43.5%
Contract with Customer, Liability, Current 2,399,000 USD
Liabilities, Current 195,487,000 USD +89.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 104,112,000 USD -6.2%
Other Liabilities, Noncurrent 669,000 USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 6,443,000 USD +35.6%
Retained Earnings (Accumulated Deficit) -1,627,154,000 USD -0.1%
Stockholders' Equity Attributable to Parent 466,052,000 USD +1.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 503,416,000 USD +1.6%
Liabilities and Equity 1,385,295,000 USD +21.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -146,272,000 USD -24.1%
Net Cash Provided by (Used in) Financing Activities 20,634,000 USD +76.3%
Net Cash Provided by (Used in) Investing Activities 76,910,000 USD +18.6%
Common Stock, Shares Authorized 290,000,000 shares 0%
Common Stock, Shares, Issued 135,702,000 shares +9.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 226,548,000 USD +1.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 497,543,000 USD +10.8%
Deferred Tax Assets, Gross 562,686,000 USD +19%
Operating Lease, Liability 111,401,000 USD -5.1%
Payments to Acquire Property, Plant, and Equipment 7,516,000 USD -89.1%
Lessee, Operating Lease, Liability, to be Paid 173,558,000 USD -7.9%
Property, Plant and Equipment, Gross 462,684,000 USD +4.2%
Operating Lease, Liability, Current 7,289,000 USD +14.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15,050,000 USD -4.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 15,873,000 USD +2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 62,157,000 USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13,696,000 USD -8.5%
Deferred Tax Assets, Operating Loss Carryforwards 70,858,000 USD -31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits 22,152,000 USD +33.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13,985,000 USD +2.7%
Operating Lease, Payments 15,474,000 USD +40.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1,700,000 USD 0%
Depreciation, Depletion and Amortization 22,200,000 USD +31.4%
Share-based Payment Arrangement, Expense 54,848,000 USD -18.3%
Interest Expense 23,031,000 USD +43.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%